Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Chimeric Therapeutics Limited has announced the issuance of 20 million unquoted equity securities in the form of options, which are set to be issued on May 13, 2024. These options, detailed in the company’s recent Appendix 3G filing, will have varying expiration dates and exercise prices. This move is part of the company’s employee incentive scheme and will not be quoted on the ASX.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.
